Evaluation of Bone Turnover in Patients With Type 1 Diabetes Mellitus

Sain Safarova

Abstract


Background: The purpose of the study was to assess the effect of changes in male and female’s body with type 1 diabetes mellitus (T1DM) on the state of the bone mineral density and the metabolic rate, and to determinate the direction of changes in serum markers of bone remodeling and bone mineral density in both sexes due to this disease.

Methods: Bone mineral density (with dual-energy X-ray absorptiometry (DXA)) and serum bone remodeling markers (alkaline phosphatase (ALP), procollagen type 1 intact N-terminal propeptide (P1NP) and C-terminal cross-linking telopeptide of type I collagen (b-CTx)) were measured in 57 female and 41 male with T1DM (n = 98) and in a group control, consisting of 43 female and 39 male (n = 82).

Results: Analysis of the obtained results showed lower values in all the surveyed areas of patients with diabetes, in comparison with the control group. It was found that the studied bone formation markers (ALP, P1NP) behave differently. While the P1NP level is significantly reduced in female with T1DM vs. control group patients (P < 0.001), the level of ALP was comparable between the groups of patients with T1DM and control (P > 0.05). B-CTx showed a significant negative correlation with the T-score of lumbar spine (r = -0.431, P = 0.000).

Conclusions: Based on the results of studying the T-score it was found that in male and female with diabetes, in comparison with the control group, the bone density in the vertebrae was reduced. In men with T1DM changes in the T-score in the spine were found less intense than those in female.




J Endocrinol Metab. 2018;8(1):2-5
doi: https://doi.org/10.14740/jem483w

 


Keywords


Diabetes mellitus type 1; Bone mineral density; Osteoporosis

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

DECLARATION: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!